Rigel Pharma (NASDAQ: RIGL) surges on talk of PDUFA approval of TAVALISSE, per a post on the company's website:"Rigel Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE